Future of cell and gene therapies for Parkinson's disease. - Wikidata - awgldk - TriplyDB

Future of cell and gene therapies for Parkinson's disease.

Future of cell and gene therapies for Parkinson's disease.

http://www.wikidata.org/entity/Q37696495

about

Gene therapy in Parkinson's disease: rationale and current status The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies Neuromechanical principles underlying movement modularity and their implications for rehabilitation Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools.A dual-hit animal model for age-related parkinsonism.Recent advances in lentiviral vector development and applications.Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function.Pluripotent stem cells for Parkinson's disease: progress and challenges.Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.Transplantation of Airway Epithelial Stem/Progenitor Cells: A Future for Cell-Based Therapy.Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity.Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1.

P2860

Q22241423-B7729308-AB44-417C-891B-5AE5074357EA Q24605294-7A84A36E-5242-4223-B693-5CAA5C8297C8 Q28088572-2DEC5BD7-2EB0-4E6A-88EF-12B8DE1C372E Q33758221-1FC043B3-20CC-4AB8-BD12-124294F1DEBF Q35614156-BF9AEF4E-C7DB-440D-BFEF-74D3B0C001BA Q36373006-8C7133A9-0BB4-4B9C-810E-D04CD109981E Q37419156-DAEAC5A4-84BB-4AB7-A2C9-61A1ED95EDFA Q37620482-A40ADE57-909B-4917-B445-EEF62CD06987 Q37678176-E93163F7-9406-4993-AA0D-24A7F3F24DB9 Q37989402-A339DFDC-93E9-4F8C-A0B6-2DAED76B1E9F Q38106771-074BEC22-34A4-4171-96EC-38F98FB3F6B7 Q38703346-388279BF-69A9-42CC-9696-5DB34B8EEB4B Q38820891-B6C95FF5-E62C-498C-A726-598A290A916D Q39507945-AEB3AA1B-0532-4314-9554-1FF2F4DE7881 Q48710371-EB96A8A6-7CED-47EC-B9AE-86D158DA37A4

P2860

Future of cell and gene therapies for Parkinson's disease.

http://www.wikidata.org/entity/Q37696495

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Future of cell and gene therapies for Parkinson's disease.

@en

Future of cell and gene therapies for Parkinson's disease.

@nl

type

label

Future of cell and gene therapies for Parkinson's disease.

@en

Future of cell and gene therapies for Parkinson's disease.

@nl

prefLabel

Future of cell and gene therapies for Parkinson's disease.

@en

Future of cell and gene therapies for Parkinson's disease.

@nl

P1433

Q37696495-FC8BD0C9-A53D-4DA9-8800-E2987CEC1260

P1476

Q37696495-A3F9358C-E9BD-4550-9599-B9F5DF326C43

P2093

Q37696495-E7F27E44-6C70-4FB2-A4BD-58C780772D1D

P2860

Q37696495-01D22E03-ACD0-4E28-BACD-563B050B6043

Q37696495-01E165CC-1F4C-44DD-B335-0879358BB2CF

Q37696495-020F392D-02CA-44F3-BC42-A5CD2F696AF5

Q37696495-026C1304-6A83-4512-855E-D102270AE681

Q37696495-042CE0DE-BB09-4634-81AA-22E1D45B3741

Q37696495-059A5F6A-41D2-41B1-9897-FD395C295545

Q37696495-09422594-59EA-4B5E-9F0C-0033C643E485

Q37696495-0A1E884A-BE57-4796-A141-683C65AAA8B9

Q37696495-0CB6A571-7D03-4018-B4DD-AF75715FD56C

Q37696495-0DC72668-A597-4EA9-B3C8-A659D4176CAE

P304

Q37696495-C6132B51-FA59-4EA0-AE51-E15020669AFA

P31

Q37696495-D4DCFF56-A376-4BEF-83B1-9A21F7D43537

P356

Q37696495-6A00622E-D29B-47EC-BD05-6D73D74736F5

P433

Q37696495-675A3CCF-718E-4215-803F-2A0A3A03A7FE

P478

Q37696495-F3B7CCA3-3355-44DF-BB7F-9F42EAB4028D

P50

Q37696495-E05755AA-5042-45E6-BD64-918B1A79CEF4

P577

Q37696495-B2AAE348-D910-444C-898E-E00F1E46DD39

P698

Q37696495-FB7C341F-659A-4BAF-A795-6B6500EB9FA5

P921

Q37696495-678FD741-7C75-4A5F-BCF3-9030AF9773CE

P932

Q37696495-F8F88376-7126-4E76-9331-65A5033E0767

P356

P1433

Annals of Neurology

P1476

Future of cell and gene therapies for Parkinson's disease.

@en

P2093

Ole Isacson

http://www.w3.org/2001/XMLSchema#string

P2860

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons

In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

Crossroads in GDNF therapy for Parkinson's disease

AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease

P304

S122-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21473

http://www.w3.org/2001/XMLSchema#string

P433

S2

http://www.w3.org/2001/XMLSchema#string

P478

64 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey H Kordower

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19127583

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3982797

http://www.w3.org/2001/XMLSchema#string